| RS1553177688 |
SDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary pheochromocytoma and paraganglioma, Gastrointestinal stromal tumor |
| RS1553177690 |
SDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Pheochromocytoma/paraganglioma syndrome 4, Gastrointestinal stromal tumor |
| RS1553177739 |
SDHB
|
Health Risk |
Pathogenic |
Hereditary pheochromocytoma and paraganglioma, Gastrointestinal stromal tumor |
| RS1553177741 |
SDHB
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1553177742 |
SDHB
|
Health Risk |
Pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS1553177768 |
SDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Pheochromocytoma/paraganglioma syndrome 4, Gastrointestinal stromal tumor |
| RS1553177769 |
SDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Gastrointestinal stromal tumor |
| RS1553177772 |
SDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary pheochromocytoma and paraganglioma, Gastrointestinal stromal tumor |
| RS1553178040 |
SDHB
|
Health Risk |
Pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS1553178041 |
SDHB
|
Health Risk |
Pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS1553178047 |
NPHP4
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephronophthisis 4, Senior-Loken syndrome 4 |
| RS1553178276 |
AGRN
|
Health Risk |
Likely pathogenic |
— |
| RS1553178399 |
SARS1
|
Health Risk |
Pathogenic |
Cerebral arteriovenous malformation, Cerebral arteriovenous malformation |
| RS1553178726 |
SDHB
|
Health Risk |
Likely pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma/paraganglioma syndrome 4 |
| RS1553178729 |
SDHB
|
Health Risk |
Pathogenic |
Pheochromocytoma, Gastrointestinal stromal tumor |
| RS1553178737 |
SDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Pheochromocytoma |
| RS1553179312 |
SDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Pheochromocytoma |
| RS1553179313 |
SDHB
|
Health Risk |
Pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS1553179337 |
SDHB
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1553179340 |
SDHB
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma/paraganglioma syndrome 4 |
| RS1553179359 |
SDHB
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary pheochromocytoma and paraganglioma |
| RS1553180057 |
STIL
|
Health Risk |
Pathogenic |
— |
| RS1553180342 |
NFIA
|
Health Risk |
Pathogenic |
— |
| RS1553181257 |
KCNA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 32 |
| RS1553181280 |
KCNA2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 32 |
| RS1553181282 |
KCNA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 32 |
| RS1553181301 |
KCNA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 32 |
| RS1553181323 |
KCNA2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 32 |
| RS1553181370 |
KCNA2
|
Health Risk |
Likely pathogenic |
Seizure, Seizure |
| RS1553181398 |
KCNA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 32 |
| RS1553181400 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1553182933 |
NFIA
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553182964 |
NFIA
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553183148 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1553183178 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1553183220 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1553183359 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1553183771 |
PARS2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553184620 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1553184657 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1553185069 |
MTHFR
|
Health Risk |
Likely pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS1553185268 |
AGL
|
Health Risk |
Likely pathogenic |
— |
| RS1553185302 |
AGL
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Glycogen storage disease type III |
| RS1553185403 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1553185418 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1553185474 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1553185497 |
MTHFR
|
Health Risk |
Likely pathogenic |
— |
| RS1553185883 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1553185905 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1553186489 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1553186509 |
ABCA4
|
Health Risk |
Likely pathogenic |
Congenital stationary night blindness, Congenital stationary night blindness |
| RS1553186514 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1553186577 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1553186613 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1553186896 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Stargardt disease |
| RS1553187160 |
ABCA4
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 3, Cone-rod dystrophy 3 |
| RS1553187162 |
ABCA4
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1553187228 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS1553187237 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1553187352 |
MTHFR
|
Health Risk |
Conflicting classifications of pathogenicity |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS1553187362 |
GATAD2B
|
Health Risk |
Likely pathogenic |
Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome, Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome |
| RS1553187443 |
GATAD2B
|
Health Risk |
Pathogenic |
Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome, Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome |
| RS1553187446 |
GATAD2B
|
Health Risk |
Pathogenic |
Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome, Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome |
| RS1553187509 |
MTHFR
|
Health Risk |
Likely pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS1553187583 |
GATAD2B
|
Health Risk |
Pathogenic |
— |
| RS1553187606 |
GATAD2B
|
Health Risk |
Pathogenic |
— |
| RS1553187939 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Stargardt disease, Stargardt disease |
| RS1553187957 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1553188013 |
MTHFR
|
Health Risk |
Conflicting classifications of pathogenicity |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS1553188054 |
GATAD2B
|
Health Risk |
Pathogenic |
GATAD2B-related disorder, GATAD2B-related disorder |
| RS1553188071 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1553188314 |
GATAD2B
|
Health Risk |
Pathogenic |
Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome, Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome |
| RS1553188335 |
GATAD2B
|
Health Risk |
Pathogenic |
— |
| RS1553188463 |
GATAD2B
|
Health Risk |
Pathogenic |
Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome, Intellectual disability |
| RS1553188559 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1553188588 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS1553188682 |
ABCA4
|
Health Risk |
Likely pathogenic |
Severe early-childhood-onset retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS1553188832 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1553188849 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1553188916 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Cone-rod dystrophy 3, Severe early-childhood-onset retinal dystrophy |
| RS1553189179 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe early-childhood-onset retinal dystrophy, Retinal dystrophy |
| RS1553189468 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1553189507 |
ABCA4
|
Health Risk |
Likely pathogenic |
Severe early-childhood-onset retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS1553189680 |
GATAD2B
|
Health Risk |
Pathogenic |
— |
| RS1553189681 |
GATAD2B
|
Health Risk |
Pathogenic |
Glioma susceptibility 1, Glioma susceptibility 1 |
| RS1553189700 |
GATAD2B
|
Health Risk |
Pathogenic |
— |
| RS1553189704 |
GATAD2B
|
Health Risk |
Pathogenic |
— |
| RS1553189874 |
SKI
|
Health Risk |
Conflicting classifications of pathogenicity |
Shprintzen-Goldberg syndrome, Shprintzen-Goldberg syndrome |
| RS1553189986 |
SKI
|
Health Risk |
Pathogenic |
Shprintzen-Goldberg syndrome, Shprintzen-Goldberg syndrome |
| RS1553190285 |
ATP1A1
|
Health Risk |
Pathogenic |
Charcot-Marie-tooth disease, axonal |
| RS1553190316 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1553190559 |
ABCA4
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1553190579 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy 3, Cone-rod dystrophy 3 |
| RS1553190664 |
ABCA4
|
Health Risk |
Pathogenic |
Severe early-childhood-onset retinal dystrophy, Retinal dystrophy |
| RS1553190751 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1553191001 |
CDC14A
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 32, Monogenic hearing loss |
| RS1553191393 |
GNB1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553191394 |
LORICRIN
|
Health Risk |
Pathogenic |
— |
| RS1553191909 |
CASQ2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1553192086 |
ATP1A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-tooth disease, axonal |